Aarti Drugs (India) Today
| AARTIDRUGS | 449.25 5.50 1.21% |
Performance0 of 100
| Odds Of DistressLess than 1
|
Aarti Drugs is selling at 449.25 as of the 25th of November 2024; that is 1.21 percent decrease since the beginning of the trading day. The stock's lowest day price was 439.3. Aarti Drugs has a very small chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Aarti Drugs Limited are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 4th of June 2023 and ending today, the 25th of November 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | Category Healthcare | Classification Health Care |
Aarti Drugs is entity of India. It is traded as Stock on NSE exchange. The company has 91.27 M outstanding shares. More on Aarti Drugs Limited
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Aarti Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Aarti Drugs' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Aarti Drugs or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Thematic Idea | Drugs (View all Themes) | ||||
| Business Concentration | Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Drugs, Health Care, Pharmaceuticals, Drug Manufacturers-Specialty & Generic, Healthcare (View all Sectors) | ||||
Aarti Drugs' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Aarti Drugs' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Debt LevelsAarti Drugs can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Aarti Drugs' financial leverage. It provides some insight into what part of Aarti Drugs' total assets is financed by creditors.
| |||||
Aarti Drugs Limited (AARTIDRUGS) is traded on National Stock Exchange of India in India and employs 1,064 people. Aarti Drugs is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with a current market capitalization of 41 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Aarti Drugs's market, we take the total number of its shares issued and multiply it by Aarti Drugs's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Aarti Drugs Limited operates under Pharmaceuticals sector and is part of Health Care industry. The entity has 91.27 M outstanding shares.
Aarti Drugs generates positive cash flow from operations, but has no cash available
Check Aarti Drugs Probability Of Bankruptcy
Ownership AllocationAarti Drugs holds a total of 91.27 Million outstanding shares. Aarti Drugs Limited shows majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 61.84 percent of Aarti Drugs Limited outstanding shares that are owned by insiders signifies that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Aarti Ownership Details
Aarti Drugs Limited Risk Profiles
Although Aarti Drugs' alpha and beta are two of the key measurements used to evaluate Aarti Drugs' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 0.954 | |||
| Standard Deviation | 1.54 | |||
| Variance | 2.37 | |||
| Risk Adjusted Performance | (0.12) |
Aarti Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Aarti Drugs without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Theme Ratings Now
Theme RatingsDetermine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |
| All Next | Launch Module |
Aarti Drugs Corporate Management
Elected by the shareholders, the Aarti Drugs' board of directors comprises two types of representatives: Aarti Drugs inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Aarti. The board's role is to monitor Aarti Drugs' management team and ensure that shareholders' interests are well served. Aarti Drugs' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Aarti Drugs' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Harshit Savla | Joint Director | Profile | |
| Rushikesh Deole | Company Officer | Profile | |
| Prakash Patil | MD, Chairman | Profile | |
| Dhanaji Kakade | Vice Technical | Profile | |
| Vishwa Savla | Director Sciences | Profile | |
| Adhish Patil | CFO Director | Profile | |
| Rashesh Gogri | MD Director | Profile |
Additional Tools for Aarti Stock Analysis
When running Aarti Drugs' price analysis, check to measure Aarti Drugs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aarti Drugs is operating at the current time. Most of Aarti Drugs' value examination focuses on studying past and present price action to predict the probability of Aarti Drugs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aarti Drugs' price. Additionally, you may evaluate how the addition of Aarti Drugs to your portfolios can decrease your overall portfolio volatility.